Abstract
Background
Late infection is the second most frequent early complication after total hip arthroplasty (THA) and the most frequent after hemiarthroplasty. Known risk factors for infection after THA include posttraumatic osteoarthritis, previous surgery, chronic liver disease, corticoid therapy, and excessive surgical time. However, risk factors for hemiarthroplasty are not clearly established.
Questions/purposes
We therefore determined the preoperative and intraoperative risk factors for late infection (more than 3 months after surgery) in patients with hemiarthroplasties and THAs.
Methods
We retrospectively compared 47 patients with a hip arthroplasty (23 hemiarthroplasties, 24 total hip arthroplasties) and late infection with 200 randomly-selected patients with primary arthroplasty (100 hemiarthroplasties, 100 total hip arthroplasties) during the same time period of time without any infection during followup. Potential risk factors were identified from medical records. Minimum followup was 12 months (mean, 27 months; range, 12–112 months) for the study group and 18 months (mean, 84 months; range, 18–144 months) for the control group.
Results
The following factors were more frequent in late infected hemiarthroplasties: female gender; previous surgery; obesity (body mass index greater than 30 kg/m2); glucocorticoid and immunosuppressant treatments; prolonged surgical time; inadequate antibiotic prophylaxis; prolonged wound drainage; hematoma; dislocation; and cutaneous, urinary, and/or abdominal infections. The following were more frequent in infected total hip arthroplasties: posttraumatic osteoarthritis; previous surgery; glucocorticoids; chronic liver disease; alcohol and intravenous drug abuse; prolonged surgical time; prolonged wound drainage; dislocation; subsequent surgery; and cutaneous, urinary, respiratory and abdominal infections. Diabetes did not appear to be a risk factor.
Conclusions
Our data suggest there are specific risk factors for infection in hemiarthroplasties. The major risk factors for late infection in hip arthroplasty must be recognized so they can be minimized or controlled if not possible to employ prophylactic measures.
Level of Evidence
Level III, prognostic study. See Guidelines for Authors for a complete description of levels of evidence.
Similar content being viewed by others
References
Albuhairan B, Hind D, Hutchinson A. Antibiotic prophylaxis for wound infections in total joint arthroplasty: a systematic review. J Bone Joint Surg Br. 2008;90:915–919.
American Urological Association and American Academy of Orthopaedic Surgeons. Antibiotic prophylaxis for urological patients with total joint replacements. J Urol. 2003;169:1796–1797.
Andrews H, Arden GP, Hart GM, Owen JW. Deep infection after total hip replacement. J Bone Joint Surg Br. 1981;63:53–57.
Ariza J, Euba G, Murillo O. Orthopaedic device-related infections [in Spanish]. Enferm Infect Microbiol Clin. 2008;26:380–390.
Berbari E, Hanssen A, Duffy M. Risk factors for prosthetic joint infection: case control study. Clin Infect Dis. 1998;27:1247–1254.
Bongartz T, Halligan CS, Osmon DR, Reinalda MS, Bamlet WR, Crowson CS, Hanssen AD. Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis. Arthritis Rheum. 2008;59:1713–1720.
Cierny G III, DiPasquale D. Periprosthetic total joint infections: staging, treatment, and outcomes. Clin Orthop Relat Res. 2002;403:23–28.
Cohen J. A power primer. Psychol Bull. 1992;112:155–159.
Cohen SM, Te HS, Levitsky JL. Operative risk of total hip and knee arthroplasty in cirrhotic patients. J Arthroplasty. 2005;20:460–466.
Cumming D, Parker MJ. Urinary catheterization and deep wound infection after hip fracture surgery. Int Orthop. 2007;31:483–485.
Davidson D, Pike J, Garbuz D, Duncan CP, Masri BA. Intraoperative periprosthetic fractures during total hip arthroplasty. Evaluation and management. J Bone Joint Surg Am. 2008;90:2000–2012.
Engh CA, Glassman AH, Suthers KE. The case for porous-coated hip implants. The femoral side. Clin Orthop. 1990;261:63–81.
Eskelinen A, Paavolainen P, Helenius I, Pulkkinen P, Remes V. Total hip arthroplasty for rheumatoid arthritis in younger patients: 2,557 replacements in the Finnish Arthroplasty Register followed for 0-24 years. Acta Orthop. 2006;77:853–865.
Esterhai JL, Rao N. The Epidemiology of Musculoskeletal Infections. In: Cierny G III, McLaren AC, Wongworawat MD, eds. Orthopaedic Knowledge Update: Musculoskeletal Infection. Rosemont, IL: American Academy of Orthopaedic Surgeons; 2009:3–14.
Gaine WJ, Ramamohan NA, Hussein NA, Hullin MG, McCreath SW. Wound infection in hip and knee arthroplasty. J Bone Joint Surg Br. 2000;82:561–565.
Habermann B, Eberhardt C, Kurth AA. Total joint replacement in HIV positive patients. J Infect. 2008;57:41–46.
Jain NB, Guller U, Pietrobon R, Bond TK, Higgins LD. Comorbidities increase complication rates in patients having arthroplasty. Clin Orthop Relat Res. 2005;435:232–238.
Keating EM. Current options and approaches for blood management in orthopaedic surgery. Instr Course Lect. 1999;48:655–665.
Kurtz SM, Lau E, Schmier J, Ong KL, Zhao K, Parvizi J. Infection burden for hip and knee arthroplasty in the United States. J Arthroplasty. 2008;23:984–991.
Lai K, Bohm ER, Burnell C, Hedden DR. Presence of medical comorbidities in patients with infected primary hip or knee arthroplasties. J Arthroplasty. 2007;22:651–656.
LaPorte DM, Waldman BJ, Mont MA, Hungerford DS. Infections associated with dental procedures in total hip arthroplasty. J Bone Joint Surg Br. 1999;81:56–59.
Leong G, Wilson J, Charlett A. Duration of operation as a risk factor for surgical site infection: comparison of English and US data. J Hosp Infect. 2006;63:255–262.
Lockhart PB, Loven B, Brennan MT, Fox PC. The evidence base for the efficacy of antibiotic prophylaxis in dental practice. J Am Dent Assoc. 2007;138:458–474.
Lübbeke A, Stern R, Garavaglia G, Zurcher L, Hoffmeyer P. Differences in outcomes of obese women and men undergoing primary total hip arthroplasty. Arthritis Rheum. 2007;57:327–334.
Maderazo EG, Judson S, Pasternak H. Late infection in total joint prosthesis: a review and recommendations for prevention. Clin Orthop Relat Res. 1988;229:131–142.
Meehan J, Jamali AA, Nguyen H. Prophylactic antibiotics in hip and knee arthroplasty. J Bone Joint Surg Am. 2009;91:2480–2490.
Moore MS, McAuley JP, Young AM, Engh CA Jr. Radiographic signs of osseointegration in porous-coated acetabular components. Clin Orthop. 2006;444:176–183.
Nowicki P, Chaudhary H. Total hip replacement in renal transplant patients. J Bone Joint Surg Br. 2007;89:1561–1566.
Osmon DR, Hanssen A. Prosthetic joint infections. In: Cierny G III, McLaren AC, Wongworawat MD, eds. Orthopaedic Knowledge Update: Musculoskeletal Infection. Rosemont, IL: American Academy of Orthopaedic Surgeons; 2009:165–173.
Oswald TF, Gould FK. Dental treatment and prosthetic joints: antibiotics are not the answer! J Bone Joint Surg Br. 2008;90:825–826.
Parvizi J, Morrison WB, Alavi A. Diagnostic imaging of periprosthetic joint infections. In: Cierny G III, McLaren AC, Wongworawat MD, eds. Orthopaedic Knowledge Update: Musculoskeletal Infection. Rosemont, IL: American Academy of Orthopaedic Surgeons; 2009:67–72.
Patel VP, Walsh M, Sehgal B, Preston C, DeWal H, Di Cesare PE. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2007;89:33–38.
Ridgeway S, Wilson J, Charlet A, Kafatos G, Pearson A, Coello R. Infection of the surgical site after arthroplasty of the hip. J Bone Joint Surg Br. 2005;87:844–850.
Robbins GM, Masri BA, Garbuz DS, Duncan CP. Primary total hip arthroplasty after infection. Instr Course Lect. 2001;50:317–333.
Rodríguez-Baño J, Del Toro MD, Lupión C, Suárez AI, Silva L, Nieto I, Muniain MA. Arthroplasty-related infection: incidence, risk factors, clinical features and outcome. Enferm Infect Microbiol Clin. 2008;26:614–620.
Rogmark C, Carlsson A, Johnell O, Sernbo I. Primary hemiarthroplasty in old patients with displaced femoral neck fracture: a 1-year follow-up of 103 patients aged 80 years or more. Acta Orthop Scand. 2002;73:605–610.
Saleh K, Olson M, Resig S, Bershadsky B, Kuskowski M, Gioe T, Robinson H, Schmidt R, McElfresh E. Predictors of wound infection in hip and knee joint replacement: results from a 20 year surveillance program. J Orthop Res. 2002;20:506–515.
Salvati EA, Della Valle AG, Masri BA, Duncan CP. The infected total hip arthroplasty. Instr Course Lect. 2003;52:223–246.
Salvati EA, Im VC, Aglietti P, Wilson PD Jr. Radiology of total hip replacements. Clin Orthop Relat Res. 1976;121:74–82.
Shrader MW, Schall D, Parvizi J, McCarthy JT, Lewallen DG. Total hip arthroplasty in patients with renal failure: a comparison between transplant and dialysis patients. J Arthroplasty. 2006;21:324–329.
Southwell-Keely J, Russo R, March L, Cumming R, Cameron I, Brnabic A. Antibiotic prophylaxis in hip fracture surgery: a metaanalysis. Clin Orthop Relat Res. 2004;419:179–184.
Tigges S, Stiles RG, Robertson JR. Appearance of septic hip prostheses on plain radiographs. AJR Am J Roentgenol. 1994;163:377–380.
Tsukayama D, Estrada R, Gustilo RB. Infection after total hip arthroplasty: A study of the treatment of one hundred and six infections. J Bone Joint Surg Am. 1996;78:512–523.
Van Kasteren ME, Manniën J, Ott A, Kullberg BJ, De Boer AS, Gyssens IC. Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor. Clin Infect Dis. 2007;44:921–927.
Wayne AS, Zelikof SB, Sledge CB. Total hip arthroplasty in beta-thalassemia. Case report and review of the literature. Clin Orthop Relat Res. 1993;294:149–154.
Wroblewski BM, Siney PD, Fleming PA. Charnley low-frictional torque arthroplasty in young rheumatoid and juvenile rheumatoid arthritis: 292 hips followed for an average of 15 years. Acta Orthop. 2007;78:206–210.
Acknowledgments
We thank Maria José de Dios for her help with statistical analysis and Carol Fox Warren for her help with grammatical correction.
Author information
Authors and Affiliations
Corresponding author
Additional information
Each author certifies that he or she has no commercial associations (eg, consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article.
Each author certifies that his or her institution approved the human protocol for this investigation, that all investigations were conducted in conformity with ethical principles of research, and that informed consent for participation in the study was obtained.
This work was performed at Hospital Universitario La Princesa, University Hospital integrated in Universidad Autónoma de Madrid, Madrid, Spain.
About this article
Cite this article
Cordero-Ampuero, J., de Dios, M. What Are the Risk Factors for Infection in Hemiarthroplasties and Total Hip Arthroplasties?. Clin Orthop Relat Res 468, 3268–3277 (2010). https://doi.org/10.1007/s11999-010-1411-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11999-010-1411-8